United States vs Fidalgis Font

SHARE: Share on Facebook Share on Facebook Share on Google+

In a significant victory for the defense, attorney Marc Seitles successfully represented Fidalgis Font, the CEO of Tellus Clinical Research, in a medical fraud case involving alleged “fake” clinical drug trials. Font was acquitted of all federal charges including conspiracy, wire fraud, mail fraud and money laundering brought by the Department of Justice. Seitles argued that Font, as the clinic owner, had no direct involvement in the drug trials conducted at her clinic. The jury carefully examined the evidence and concluded that witnesses were clearly lying and that the government had not met its burden of proof. The defense’s success highlights Seitles’ effective representation and his ability to dismantle the prosecution’s case.

  • Read the press articles here.
  • Read Blog Post here.